patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Good news for those who own this stock (as I do). If, however,
again. I would love to see this stock at $10. I would gladly take that profit....
Share
New Message
Please login to post a reply